Table 1.
Clinical findings for patients with CMV anterior uveitis
| Patient | Sex | Age at onset of antiviral treatment (years) | Follow-up time after starting antiviral therapy (months) | Duration of symptoms (years) | Eye | CMV DNA copy number | Coin-shaped lesions | Iris atrophy | Corneal endothelial damage (cells/mm2) | Glaucoma | Max IOP (mmHg) | Systemic therapy | Topical therapy | Successful termination of systemic therapy |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | M | 60 | 64 | 19 | OD | 12,000 | + | + | + (436) | + | 30 | valGCV | GCV | No |
| 2 | M | 74 | 65 | Unknown | OD | 5,100 | + | + | + (654) | − | 34 | valGCV | GCV | No |
| GCV | ||||||||||||||
| 3 | F | 58 | 33 | 3 | OS | 180 | + | + | + (1,392) | + | 60 | valGCV | GCV | No |
| 4 | M | 57 | 18 | 16 | OD | 59,000 | − | + | − (2,170) | − | 30 | valGCV | GCV | Yes |
| 5 | M | 56 | 17 | 8 | OD | 470 | + | + | + (1,291) | + | 46 | valGCV | GCV | No |
| 6 | M | 57 | 12 | 31 | OD | 120 | + | + | + (1,129) | − | 42 | valGCV | GCV | Yes |
| 7 | M | 44 | 14 | 2 | OS | 3,000 | + | + | − (2,801) | − | 41 | valGCV | GCV | Yes |
| 8 | F | 77 | 17 | Unknown | OS | 62,000 | − | − | + (1,100) | + | 43 | valGCV | GCV | Yes |
| 9 | M | 73 | 15 | 2 | OS | 170,000 | + | + | + (1,209) | − | 26 | valGCV | GCV | Yes |
| 10 | M | 58 | 4 | 2 | OD | 1,600 | + | + | − (2,169) | + | 44 | valGCV | GCV | No |
| 11 | M | 87 | 16 | 6 | OD | 210,000 | + | + | − (2,557) | + | 46 | valGCV | GCV | Yes |
| 12 | F | 60 | 61 | Unknown | OD | + | − | − (2,150) | − | 36 | valGCV | GCV | Yes | |
| OS | 6,800 | + | − | − (2,666) | − | 43 | ||||||||
| 13 | F | 54 | 36 | 7 | OD | 10,000 | + | + | + (550) | + | 40 | valGCV | GCV | No |
| OS | + | + | + (941) | + | 25 | |||||||||
| 14 | M | 69 | 2 | 2 | OD | 1,600 | − | − | − (2,001) | + | 43 | valGCV | GCV | No |
| OS | − | − | − (2,342) | + | 44 |
Abbreviations: CMV, cytomegalovirus; M, male; F, female; IOP, intraocular pressure; Max, maximum; valGCV, valganciclovir; GCV, ganciclovir.